- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
The Gene Delivery Systems market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Gene Delivery Systems market size is estimated to be worth US$ 516580 million in 2021 and is forecast to a readjusted size of USD 667630 million by 2028 with a CAGR of 3.7% during review period. Infectious Diseases accounting for % of the Gene Delivery Systems global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Viral Gene Delivery System segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Gene Delivery Systems include Novartis, Amgen, Oxford BioMedica, SIBIONO, and Shanghai Sunway Biotech, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Gene Delivery Systems market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Viral Gene Delivery System
Non-viral Gene Delivery System
Combined Hybrid System
Market segment by Application, can be divided into
Infectious Diseases
Oncology
Ophthalmology
Urology
Diabetes
CNS
Others
Market segment by players, this report covers
Novartis
Amgen
Oxford BioMedica
SIBIONO
Shanghai Sunway Biotech
Roche
Pfizer
Bayer
Johnson & Johnson
Becton Dickinson
AstraZeneca
Baxter
HSCI
Epeius Biotechnologies
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Gene Delivery Systems product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Gene Delivery Systems, with revenue, gross margin and global market share of Gene Delivery Systems from 2019 to 2022.
Chapter 3, the Gene Delivery Systems competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Gene Delivery Systems market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Gene Delivery Systems research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Gene Delivery Systems
1.2 Classification of Gene Delivery Systems by Type
1.2.1 Overview: Global Gene Delivery Systems Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Gene Delivery Systems Revenue Market Share by Type in 2021
1.2.3 Viral Gene Delivery System
1.2.4 Non-viral Gene Delivery System
1.2.5 Combined Hybrid System
1.3 Global Gene Delivery Systems Market by Application
1.3.1 Overview: Global Gene Delivery Systems Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Infectious Diseases
1.3.3 Oncology
1.3.4 Ophthalmology
1.3.5 Urology
1.3.6 Diabetes
1.3.7 CNS
1.3.8 Others
1.4 Global Gene Delivery Systems Market Size & Forecast
1.5 Global Gene Delivery Systems Market Size and Forecast by Region
1.5.1 Global Gene Delivery Systems Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Gene Delivery Systems Market Size by Region, (2017-2022)
1.5.3 North America Gene Delivery Systems Market Size and Prospect (2017-2028)
1.5.4 Europe Gene Delivery Systems Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Gene Delivery Systems Market Size and Prospect (2017-2028)
1.5.6 South America Gene Delivery Systems Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Gene Delivery Systems Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Gene Delivery Systems Market Drivers
1.6.2 Gene Delivery Systems Market Restraints
1.6.3 Gene Delivery Systems Trends Analysis
2 Company Profiles
2.1 Novartis
2.1.1 Novartis Details
2.1.2 Novartis Major Business
2.1.3 Novartis Gene Delivery Systems Product and Solutions
2.1.4 Novartis Gene Delivery Systems Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Novartis Recent Developments and Future Plans
2.2 Amgen
2.2.1 Amgen Details
2.2.2 Amgen Major Business
2.2.3 Amgen Gene Delivery Systems Product and Solutions
2.2.4 Amgen Gene Delivery Systems Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Amgen Recent Developments and Future Plans
2.3 Oxford BioMedica
2.3.1 Oxford BioMedica Details
2.3.2 Oxford BioMedica Major Business
2.3.3 Oxford BioMedica Gene Delivery Systems Product and Solutions
2.3.4 Oxford BioMedica Gene Delivery Systems Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Oxford BioMedica Recent Developments and Future Plans
2.4 SIBIONO
2.4.1 SIBIONO Details
2.4.2 SIBIONO Major Business
2.4.3 SIBIONO Gene Delivery Systems Product and Solutions
2.4.4 SIBIONO Gene Delivery Systems Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 SIBIONO Recent Developments and Future Plans
2.5 Shanghai Sunway Biotech
2.5.1 Shanghai Sunway Biotech Details
2.5.2 Shanghai Sunway Biotech Major Business
2.5.3 Shanghai Sunway Biotech Gene Delivery Systems Product and Solutions
2.5.4 Shanghai Sunway Biotech Gene Delivery Systems Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Shanghai Sunway Biotech Recent Developments and Future Plans
2.6 Roche
2.6.1 Roche Details
2.6.2 Roche Major Business
2.6.3 Roche Gene Delivery Systems Product and Solutions
2.6.4 Roche Gene Delivery Systems Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Roche Recent Developments and Future Plans
2.7 Pfizer
2.7.1 Pfizer Details
2.7.2 Pfizer Major Business
2.7.3 Pfizer Gene Delivery Systems Product and Solutions
2.7.4 Pfizer Gene Delivery Systems Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Pfizer Recent Developments and Future Plans
2.8 Bayer
2.8.1 Bayer Details
2.8.2 Bayer Major Business
2.8.3 Bayer Gene Delivery Systems Product and Solutions
2.8.4 Bayer Gene Delivery Systems Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Bayer Recent Developments and Future Plans
2.9 Johnson & Johnson
2.9.1 Johnson & Johnson Details
2.9.2 Johnson & Johnson Major Business
2.9.3 Johnson & Johnson Gene Delivery Systems Product and Solutions
2.9.4 Johnson & Johnson Gene Delivery Systems Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Johnson & Johnson Recent Developments and Future Plans
2.10 Becton Dickinson
2.10.1 Becton Dickinson Details
2.10.2 Becton Dickinson Major Business
2.10.3 Becton Dickinson Gene Delivery Systems Product and Solutions
2.10.4 Becton Dickinson Gene Delivery Systems Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Becton Dickinson Recent Developments and Future Plans
2.11 AstraZeneca
2.11.1 AstraZeneca Details
2.11.2 AstraZeneca Major Business
2.11.3 AstraZeneca Gene Delivery Systems Product and Solutions
2.11.4 AstraZeneca Gene Delivery Systems Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 AstraZeneca Recent Developments and Future Plans
2.12 Baxter
2.12.1 Baxter Details
2.12.2 Baxter Major Business
2.12.3 Baxter Gene Delivery Systems Product and Solutions
2.12.4 Baxter Gene Delivery Systems Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 Baxter Recent Developments and Future Plans
2.13 HSCI
2.13.1 HSCI Details
2.13.2 HSCI Major Business
2.13.3 HSCI Gene Delivery Systems Product and Solutions
2.13.4 HSCI Gene Delivery Systems Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 HSCI Recent Developments and Future Plans
2.14 Epeius Biotechnologies
2.14.1 Epeius Biotechnologies Details
2.14.2 Epeius Biotechnologies Major Business
2.14.3 Epeius Biotechnologies Gene Delivery Systems Product and Solutions
2.14.4 Epeius Biotechnologies Gene Delivery Systems Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14.5 Epeius Biotechnologies Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Gene Delivery Systems Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Gene Delivery Systems Players Market Share in 2021
3.2.2 Top 10 Gene Delivery Systems Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Gene Delivery Systems Players Head Office, Products and Services Provided
3.4 Gene Delivery Systems Mergers & Acquisitions
3.5 Gene Delivery Systems New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Gene Delivery Systems Revenue and Market Share by Type (2017-2022)
4.2 Global Gene Delivery Systems Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Gene Delivery Systems Revenue Market Share by Application (2017-2022)
5.2 Global Gene Delivery Systems Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Gene Delivery Systems Revenue by Type (2017-2028)
6.2 North America Gene Delivery Systems Revenue by Application (2017-2028)
6.3 North America Gene Delivery Systems Market Size by Country
6.3.1 North America Gene Delivery Systems Revenue by Country (2017-2028)
6.3.2 United States Gene Delivery Systems Market Size and Forecast (2017-2028)
6.3.3 Canada Gene Delivery Systems Market Size and Forecast (2017-2028)
6.3.4 Mexico Gene Delivery Systems Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Gene Delivery Systems Revenue by Type (2017-2028)
7.2 Europe Gene Delivery Systems Revenue by Application (2017-2028)
7.3 Europe Gene Delivery Systems Market Size by Country
7.3.1 Europe Gene Delivery Systems Revenue by Country (2017-2028)
7.3.2 Germany Gene Delivery Systems Market Size and Forecast (2017-2028)
7.3.3 France Gene Delivery Systems Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Gene Delivery Systems Market Size and Forecast (2017-2028)
7.3.5 Russia Gene Delivery Systems Market Size and Forecast (2017-2028)
7.3.6 Italy Gene Delivery Systems Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Gene Delivery Systems Revenue by Type (2017-2028)
8.2 Asia-Pacific Gene Delivery Systems Revenue by Application (2017-2028)
8.3 Asia-Pacific Gene Delivery Systems Market Size by Region
8.3.1 Asia-Pacific Gene Delivery Systems Revenue by Region (2017-2028)
8.3.2 China Gene Delivery Systems Market Size and Forecast (2017-2028)
8.3.3 Japan Gene Delivery Systems Market Size and Forecast (2017-2028)
8.3.4 South Korea Gene Delivery Systems Market Size and Forecast (2017-2028)
8.3.5 India Gene Delivery Systems Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Gene Delivery Systems Market Size and Forecast (2017-2028)
8.3.7 Australia Gene Delivery Systems Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Gene Delivery Systems Revenue by Type (2017-2028)
9.2 South America Gene Delivery Systems Revenue by Application (2017-2028)
9.3 South America Gene Delivery Systems Market Size by Country
9.3.1 South America Gene Delivery Systems Revenue by Country (2017-2028)
9.3.2 Brazil Gene Delivery Systems Market Size and Forecast (2017-2028)
9.3.3 Argentina Gene Delivery Systems Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Gene Delivery Systems Revenue by Type (2017-2028)
10.2 Middle East & Africa Gene Delivery Systems Revenue by Application (2017-2028)
10.3 Middle East & Africa Gene Delivery Systems Market Size by Country
10.3.1 Middle East & Africa Gene Delivery Systems Revenue by Country (2017-2028)
10.3.2 Turkey Gene Delivery Systems Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Gene Delivery Systems Market Size and Forecast (2017-2028)
10.3.4 UAE Gene Delivery Systems Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Gene Delivery Systems Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Gene Delivery Systems Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Gene Delivery Systems Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Gene Delivery Systems Revenue (USD Million) by Region (2017-2022)
Table 5. Global Gene Delivery Systems Revenue Market Share by Region (2023-2028)
Table 6. Novartis Corporate Information, Head Office, and Major Competitors
Table 7. Novartis Major Business
Table 8. Novartis Gene Delivery Systems Product and Solutions
Table 9. Novartis Gene Delivery Systems Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Amgen Corporate Information, Head Office, and Major Competitors
Table 11. Amgen Major Business
Table 12. Amgen Gene Delivery Systems Product and Solutions
Table 13. Amgen Gene Delivery Systems Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Oxford BioMedica Corporate Information, Head Office, and Major Competitors
Table 15. Oxford BioMedica Major Business
Table 16. Oxford BioMedica Gene Delivery Systems Product and Solutions
Table 17. Oxford BioMedica Gene Delivery Systems Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. SIBIONO Corporate Information, Head Office, and Major Competitors
Table 19. SIBIONO Major Business
Table 20. SIBIONO Gene Delivery Systems Product and Solutions
Table 21. SIBIONO Gene Delivery Systems Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Shanghai Sunway Biotech Corporate Information, Head Office, and Major Competitors
Table 23. Shanghai Sunway Biotech Major Business
Table 24. Shanghai Sunway Biotech Gene Delivery Systems Product and Solutions
Table 25. Shanghai Sunway Biotech Gene Delivery Systems Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Roche Corporate Information, Head Office, and Major Competitors
Table 27. Roche Major Business
Table 28. Roche Gene Delivery Systems Product and Solutions
Table 29. Roche Gene Delivery Systems Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Pfizer Corporate Information, Head Office, and Major Competitors
Table 31. Pfizer Major Business
Table 32. Pfizer Gene Delivery Systems Product and Solutions
Table 33. Pfizer Gene Delivery Systems Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Bayer Corporate Information, Head Office, and Major Competitors
Table 35. Bayer Major Business
Table 36. Bayer Gene Delivery Systems Product and Solutions
Table 37. Bayer Gene Delivery Systems Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Johnson & Johnson Corporate Information, Head Office, and Major Competitors
Table 39. Johnson & Johnson Major Business
Table 40. Johnson & Johnson Gene Delivery Systems Product and Solutions
Table 41. Johnson & Johnson Gene Delivery Systems Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Becton Dickinson Corporate Information, Head Office, and Major Competitors
Table 43. Becton Dickinson Major Business
Table 44. Becton Dickinson Gene Delivery Systems Product and Solutions
Table 45. Becton Dickinson Gene Delivery Systems Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. AstraZeneca Corporate Information, Head Office, and Major Competitors
Table 47. AstraZeneca Major Business
Table 48. AstraZeneca Gene Delivery Systems Product and Solutions
Table 49. AstraZeneca Gene Delivery Systems Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Baxter Corporate Information, Head Office, and Major Competitors
Table 51. Baxter Major Business
Table 52. Baxter Gene Delivery Systems Product and Solutions
Table 53. Baxter Gene Delivery Systems Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. HSCI Corporate Information, Head Office, and Major Competitors
Table 55. HSCI Major Business
Table 56. HSCI Gene Delivery Systems Product and Solutions
Table 57. HSCI Gene Delivery Systems Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. Epeius Biotechnologies Corporate Information, Head Office, and Major Competitors
Table 59. Epeius Biotechnologies Major Business
Table 60. Epeius Biotechnologies Gene Delivery Systems Product and Solutions
Table 61. Epeius Biotechnologies Gene Delivery Systems Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 62. Global Gene Delivery Systems Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 63. Global Gene Delivery Systems Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 64. Breakdown of Gene Delivery Systems by Company Type (Tier 1, Tier 2 and Tier 3)
Table 65. Gene Delivery Systems Players Head Office, Products and Services Provided
Table 66. Gene Delivery Systems Mergers & Acquisitions in the Past Five Years
Table 67. Gene Delivery Systems New Entrants and Expansion Plans
Table 68. Global Gene Delivery Systems Revenue (USD Million) by Type (2017-2022)
Table 69. Global Gene Delivery Systems Revenue Share by Type (2017-2022)
Table 70. Global Gene Delivery Systems Revenue Forecast by Type (2023-2028)
Table 71. Global Gene Delivery Systems Revenue by Application (2017-2022)
Table 72. Global Gene Delivery Systems Revenue Forecast by Application (2023-2028)
Table 73. North America Gene Delivery Systems Revenue by Type (2017-2022) & (USD Million)
Table 74. North America Gene Delivery Systems Revenue by Type (2023-2028) & (USD Million)
Table 75. North America Gene Delivery Systems Revenue by Application (2017-2022) & (USD Million)
Table 76. North America Gene Delivery Systems Revenue by Application (2023-2028) & (USD Million)
Table 77. North America Gene Delivery Systems Revenue by Country (2017-2022) & (USD Million)
Table 78. North America Gene Delivery Systems Revenue by Country (2023-2028) & (USD Million)
Table 79. Europe Gene Delivery Systems Revenue by Type (2017-2022) & (USD Million)
Table 80. Europe Gene Delivery Systems Revenue by Type (2023-2028) & (USD Million)
Table 81. Europe Gene Delivery Systems Revenue by Application (2017-2022) & (USD Million)
Table 82. Europe Gene Delivery Systems Revenue by Application (2023-2028) & (USD Million)
Table 83. Europe Gene Delivery Systems Revenue by Country (2017-2022) & (USD Million)
Table 84. Europe Gene Delivery Systems Revenue by Country (2023-2028) & (USD Million)
Table 85. Asia-Pacific Gene Delivery Systems Revenue by Type (2017-2022) & (USD Million)
Table 86. Asia-Pacific Gene Delivery Systems Revenue by Type (2023-2028) & (USD Million)
Table 87. Asia-Pacific Gene Delivery Systems Revenue by Application (2017-2022) & (USD Million)
Table 88. Asia-Pacific Gene Delivery Systems Revenue by Application (2023-2028) & (USD Million)
Table 89. Asia-Pacific Gene Delivery Systems Revenue by Region (2017-2022) & (USD Million)
Table 90. Asia-Pacific Gene Delivery Systems Revenue by Region (2023-2028) & (USD Million)
Table 91. South America Gene Delivery Systems Revenue by Type (2017-2022) & (USD Million)
Table 92. South America Gene Delivery Systems Revenue by Type (2023-2028) & (USD Million)
Table 93. South America Gene Delivery Systems Revenue by Application (2017-2022) & (USD Million)
Table 94. South America Gene Delivery Systems Revenue by Application (2023-2028) & (USD Million)
Table 95. South America Gene Delivery Systems Revenue by Country (2017-2022) & (USD Million)
Table 96. South America Gene Delivery Systems Revenue by Country (2023-2028) & (USD Million)
Table 97. Middle East & Africa Gene Delivery Systems Revenue by Type (2017-2022) & (USD Million)
Table 98. Middle East & Africa Gene Delivery Systems Revenue by Type (2023-2028) & (USD Million)
Table 99. Middle East & Africa Gene Delivery Systems Revenue by Application (2017-2022) & (USD Million)
Table 100. Middle East & Africa Gene Delivery Systems Revenue by Application (2023-2028) & (USD Million)
Table 101. Middle East & Africa Gene Delivery Systems Revenue by Country (2017-2022) & (USD Million)
Table 102. Middle East & Africa Gene Delivery Systems Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Gene Delivery Systems Picture
Figure 2. Global Gene Delivery Systems Revenue Market Share by Type in 2021
Figure 3. Viral Gene Delivery System
Figure 4. Non-viral Gene Delivery System
Figure 5. Combined Hybrid System
Figure 6. Gene Delivery Systems Revenue Market Share by Application in 2021
Figure 7. Infectious Diseases Picture
Figure 8. Oncology Picture
Figure 9. Ophthalmology Picture
Figure 10. Urology Picture
Figure 11. Diabetes Picture
Figure 12. CNS Picture
Figure 13. Others Picture
Figure 14. Global Gene Delivery Systems Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 15. Global Gene Delivery Systems Revenue and Forecast (2017-2028) & (USD Million)
Figure 16. Global Gene Delivery Systems Revenue Market Share by Region (2017-2028)
Figure 17. Global Gene Delivery Systems Revenue Market Share by Region in 2021
Figure 18. North America Gene Delivery Systems Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. Europe Gene Delivery Systems Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. Asia-Pacific Gene Delivery Systems Revenue (USD Million) and Growth Rate (2017-2028)
Figure 21. South America Gene Delivery Systems Revenue (USD Million) and Growth Rate (2017-2028)
Figure 22. Middle East and Africa Gene Delivery Systems Revenue (USD Million) and Growth Rate (2017-2028)
Figure 23. Gene Delivery Systems Market Drivers
Figure 24. Gene Delivery Systems Market Restraints
Figure 25. Gene Delivery Systems Market Trends
Figure 26. Novartis Recent Developments and Future Plans
Figure 27. Amgen Recent Developments and Future Plans
Figure 28. Oxford BioMedica Recent Developments and Future Plans
Figure 29. SIBIONO Recent Developments and Future Plans
Figure 30. Shanghai Sunway Biotech Recent Developments and Future Plans
Figure 31. Roche Recent Developments and Future Plans
Figure 32. Pfizer Recent Developments and Future Plans
Figure 33. Bayer Recent Developments and Future Plans
Figure 34. Johnson & Johnson Recent Developments and Future Plans
Figure 35. Becton Dickinson Recent Developments and Future Plans
Figure 36. AstraZeneca Recent Developments and Future Plans
Figure 37. Baxter Recent Developments and Future Plans
Figure 38. HSCI Recent Developments and Future Plans
Figure 39. Epeius Biotechnologies Recent Developments and Future Plans
Figure 40. Global Gene Delivery Systems Revenue Share by Players in 2021
Figure 41. Gene Delivery Systems Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 42. Global Top 3 Players Gene Delivery Systems Revenue Market Share in 2021
Figure 43. Global Top 10 Players Gene Delivery Systems Revenue Market Share in 2021
Figure 44. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 45. Global Gene Delivery Systems Revenue Share by Type in 2021
Figure 46. Global Gene Delivery Systems Market Share Forecast by Type (2023-2028)
Figure 47. Global Gene Delivery Systems Revenue Share by Application in 2021
Figure 48. Global Gene Delivery Systems Market Share Forecast by Application (2023-2028)
Figure 49. North America Gene Delivery Systems Sales Market Share by Type (2017-2028)
Figure 50. North America Gene Delivery Systems Sales Market Share by Application (2017-2028)
Figure 51. North America Gene Delivery Systems Revenue Market Share by Country (2017-2028)
Figure 52. United States Gene Delivery Systems Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Canada Gene Delivery Systems Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Mexico Gene Delivery Systems Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Europe Gene Delivery Systems Sales Market Share by Type (2017-2028)
Figure 56. Europe Gene Delivery Systems Sales Market Share by Application (2017-2028)
Figure 57. Europe Gene Delivery Systems Revenue Market Share by Country (2017-2028)
Figure 58. Germany Gene Delivery Systems Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. France Gene Delivery Systems Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. United Kingdom Gene Delivery Systems Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Russia Gene Delivery Systems Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Italy Gene Delivery Systems Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Asia-Pacific Gene Delivery Systems Sales Market Share by Type (2017-2028)
Figure 64. Asia-Pacific Gene Delivery Systems Sales Market Share by Application (2017-2028)
Figure 65. Asia-Pacific Gene Delivery Systems Revenue Market Share by Region (2017-2028)
Figure 66. China Gene Delivery Systems Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Japan Gene Delivery Systems Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. South Korea Gene Delivery Systems Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. India Gene Delivery Systems Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Southeast Asia Gene Delivery Systems Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Australia Gene Delivery Systems Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. South America Gene Delivery Systems Sales Market Share by Type (2017-2028)
Figure 73. South America Gene Delivery Systems Sales Market Share by Application (2017-2028)
Figure 74. South America Gene Delivery Systems Revenue Market Share by Country (2017-2028)
Figure 75. Brazil Gene Delivery Systems Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Argentina Gene Delivery Systems Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Middle East and Africa Gene Delivery Systems Sales Market Share by Type (2017-2028)
Figure 78. Middle East and Africa Gene Delivery Systems Sales Market Share by Application (2017-2028)
Figure 79. Middle East and Africa Gene Delivery Systems Revenue Market Share by Country (2017-2028)
Figure 80. Turkey Gene Delivery Systems Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 81. Saudi Arabia Gene Delivery Systems Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 82. UAE Gene Delivery Systems Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 83. Methodology
Figure 84. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
